Skip to main content Accessibility help
×
Home
Hostname: page-component-568f69f84b-gcfkn Total loading time: 0.179 Render date: 2021-09-20T09:24:49.142Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Realizing Public Rights Through Government Patent Use

Published online by Cambridge University Press:  21 April 2021

Abstract

A substantial portion of biomedical R&D is publicly funded. But resulting medicines are typically covered by patents held by private firms, and priced without regard to the public’s investment. The Bayh-Dole Act provides a possible remedy, but its scope is limited.

Type
Symposium Articles
Copyright
© 2021 The Author(s)

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

COVID-19 Dashboard, Johns Hopkins Coronavirus Resource Center, available at <https://coronavirus.jhu.edu/map.html>(last visited Sept. 30, 2020).(last+visited+Sept.+30,+2020).>Google Scholar
COVID-19 R&D Tracker Update: 6 Aug. 2020, Policy Cures Research, available at <https://bit.ly/38W5JQD> (last visited Sept. 28, 2020).+(last+visited+Sept.+28,+2020).>Google Scholar
Beigel, J., Tomashek, K., Dodd, L., Mehta, A., Zingman, B.S., Kalil, A.C., et al., “Remdesivir for the Treatment of Covid-19— Preliminary Report,New England Journal of Medicine 383 (2020): 18131826, available at <https://www.nejm.org/doi/full/10.1056/NEJMoa2007764> (last visited January 7, 2021).Google Scholar
COVID-19 Treatment Guidelines: What’s New in the Guidelines,” National Institute of Health, Sept. 1, 2020, available at <https://www.covid19treatmentguidelines.nih.gov/whats-new/> (last visited January 7, 2021).+(last+visited+January+7,+2021).>Google Scholar
Herper, M., “Gilead Announces Long-Awaited Price for Covid-19 Drug Remdesivir,” STAT News, June 29, 2020, available at <https://www.statnews.com/2020/06/29/gilead-announces-remdesivir-price-covid-19/> (last visited July 27, 2020).+(last+visited+July+27,+2020).>Google Scholar
Hill, A., Wang, J., Levi, J., Heath, K., and Fortunak, J., “Minimum Costs to Manufacture New Treatments for COVID-19,Journal of Virus Eradication 6, no. 2 (2020): 6169, available at <https://doi.org/10.1016/S2055-6640(20)30018-2> (last visited January 7, 2021).Google Scholar
“ICER Provides First Update to Pricing Models for Remde-sivir as a Treatment for COVID-19,” Institute for Clinical and Economic Review, June 24, 2020, available at <https://icer-review.org/announcements/updated_icer-covid_models_june_24/> (last visited July 27, 2020).+(last+visited+July+27,+2020).>Google Scholar
Rizvi, Z., “Gilead First: How a Monopoly on Remdesivir Led to Rationing,” Public Citizen, Sept. 2, 2020, available at <https://www.citizen.org/article/gilead-first/> (last visited January 7, 2020).+(last+visited+January+7,+2020).>Google Scholar
“Trump Administration Secures New Supplies of Remdesivir for the United States,” U.S. Department of Health and Human Services, June 29, 2020, available at <https://www.hhs.gov/about/news/2020/06/29/trump-administration-secures-new-supplies-remdesivir-united-states.html> (last visited January 7, 2021).+(last+visited+January+7,+2021).>Google Scholar
Rowland, C., “Taxpayers Paid to Develop Remdesivir But Will Have No Say When Gilead Sets the Price,” Washington Post, May 26, 2020, available at <https://www.washingtonpost.com/business/2020/05/26/remdesivir-coronavirus-taxpayers/> (last visited January 7, 2021).+(last+visited+January+7,+2021).>Google Scholar
Sarpatwari, A., Kaltenboeck, A., and Kesselheim, A.S., “Missed Opportunities on Emergency Remdesivir Use,JAMA 324, no. 4 (2020): 331332, available at <https://doi.org/10.1001/jama.2020.11932> (last visited January 7, 2021).Google Scholar
Krellenstein, J., Morten, C.J., The U.S. Government’s Apparent Co-Ownership of Patents Protecting Remdesivir (2020), available at <https://www.prep4all.org/news/remdesivir> (last visited January 7, 2021).+(last+visited+January+7,+2021).>Google Scholar
Li, D., Azoulay, P., and Sampat, B.N., “The Applied Value of Public Investments in Biomedical Research,Science 356, no. 6333 (2017): 7881.Google Scholar
Thomas, J.R., “March-In Rights Under the Bayh-Dole Act,” Congressional Research Service, Aug. 22, 2016, available at <https://fas.org/sgp/crs/misc/R44597.pdf> (last visited January 7, 2021).+(last+visited+January+7,+2021).>Google Scholar
35 U.S.C. § 201(e) (2018).Google Scholar
35 U.S.C. § 203(a) (2018).Google Scholar
Bayh, B. and Dole, R., “Our Law Helps Patients Get New Drugs Sooner,” Washington Post, April 11, 2002, at A28.Google Scholar
Thomas, supra note 19.Google Scholar
Rowland, C., “Trump Administration Makes It Easier for Drug-makers to Profit from Publicly Funded Coronavirus Drugs, Advocates Say,” Washington Post, July 1, 2020, available at <https://www.washingtonpost.com/business/2020/07/01/vaccine-coronavirus-barda-trump/> (last visited July 27,2020).+(last+visited+July+27,2020).>Google Scholar
Rowland, supra note 13.Google Scholar
Brennan, H., Kapczynski, A., Monahan, C.H., and Rizvi, Z., “A Prescription for Excessive Drug Pricing: Leveraging Government Patent Use for Health,Yale Journal of Law and Technology 18 (2016): 275354.Google Scholar
Beigel, supra note 4.Google Scholar
Supra note 8.Google Scholar
1
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Realizing Public Rights Through Government Patent Use
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Realizing Public Rights Through Government Patent Use
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Realizing Public Rights Through Government Patent Use
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *